Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin
TimesSquare Capital Management's "U.S. Small Cap Growth Strategy" saw a 5.77% return in Q1 2024, outperforming the Russell 2000 Growth Index. Highlighting Krystal Biotech, Inc.